Azenosertib in combination with bevacizumab as maintenance therapy in patients with advanced ovarian cancer: part 2 of a phase 1b study

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Joyce F. Liu, Tarek Meniaway, Gary Richardson, Siqing Fu, Premal H. Thaker, Stephanie V. Blank, Cara Amanda Mathews, Angeles Alvarez Secord, Bradley R. Corr, Ashwin Swami, Catherine Lee, Christine Burnett
+3 more Dongliang Zhuang, Nandini Molden, Sumitra S. Ananda
DOI: 10.1016/j.ijgc.2026.104611
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Endometrial and Cervical Cancer Treatments

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
104611–104611
Publication date
1 February 2026
Language
EN